Suppr超能文献

原发性醛固酮增多症患者骨密度降低的相关危险因素。

Risk Factors Associated With Lower Bone Mineral Density in Primary Aldosteronism Patients.

机构信息

Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2022 Jun 16;13:884302. doi: 10.3389/fendo.2022.884302. eCollection 2022.

Abstract

PURPOSE

The association between primary aldosteronism (PA) and lower bone mineral density (BMD) has raised a concern, but the contributing factors remain unclear. We aim to explore the risk factors for lower BMD in PA patients.

METHODS

We analyzed and compared the data of 60 PA patients with 60 matched essential hypertension (EH) patients. BMD, bone metabolites, and several oxidative stress and inflammation indicators-including C-reactive protein (CRP), superoxide dismutase (SOD), total bilirubin (TBIL), mean platelet volume (MPV), -were assessed and compared in PA and EH patients. Bivariate correlation analysis and multivariate linear regression analysis were performed to explore the factors associated with BMD in PA patients.

RESULTS

The BMD measured by quantitative computed tomography in PA patients was lower than that in EH patients (141.9 ± 34.0 vs. 158.9 ± 55.9 g/cm, = 0.047), especially in patients less than 50 years old. BMD was independently negatively associated with age (standardized = -0.581, < 0.001), serum phosphorus (standardized = -0.203, = 0.008), urinary calcium excretion (standardized = -0.185, = 0.031), and MPV (standardized = -0.172, = 0.043) and positively associated with SOD (standardized = 0.205, = 0.011) and TBIL (standardized = 0.212, = 0.015).

CONCLUSIONS

The PA patients showed a lower BMD than the EH patients, which was associated with age, serum phosphorus, urinary calcium excretion, MPV, SOD, and TBIL. These variables might be potential markers for the assessment of bone loss and efficacy of treatments in PA patients.

摘要

目的

原发性醛固酮增多症(PA)与较低的骨密度(BMD)之间存在关联,这引起了人们的关注,但导致这种关联的因素仍不清楚。我们旨在探讨 PA 患者 BMD 降低的相关危险因素。

方法

我们分析并比较了 60 例 PA 患者和 60 例匹配的原发性高血压(EH)患者的数据。评估并比较了 PA 和 EH 患者的 BMD、骨代谢物以及几种氧化应激和炎症指标,包括 C 反应蛋白(CRP)、超氧化物歧化酶(SOD)、总胆红素(TBIL)、平均血小板体积(MPV)。采用双变量相关分析和多元线性回归分析探讨与 PA 患者 BMD 相关的因素。

结果

PA 患者定量计算机断层扫描(QCT)测量的 BMD 低于 EH 患者(141.9 ± 34.0 与 158.9 ± 55.9 g/cm³, = 0.047),尤其是年龄小于 50 岁的患者。BMD 与年龄(标准化β = -0.581, < 0.001)、血清磷(标准化β = -0.203, = 0.008)、尿钙排泄量(标准化β = -0.185, = 0.031)和 MPV(标准化β = -0.172, = 0.043)呈负相关,与 SOD(标准化β = 0.205, = 0.011)和 TBIL(标准化β = 0.212, = 0.015)呈正相关。

结论

PA 患者的 BMD 低于 EH 患者,与年龄、血清磷、尿钙排泄量、MPV、SOD 和 TBIL 相关。这些变量可能是评估 PA 患者骨丢失和治疗效果的潜在标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b79/9245341/c78ccaf32dda/fendo-13-884302-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验